Loxo Oncology, Inc.·4

Jan 2, 5:06 PM ET

Burstein Jennifer 4

4 · Loxo Oncology, Inc. · Filed Jan 2, 2019

Insider Transaction Report

Form 4
Period: 2018-01-02
Burstein Jennifer
Vice President of Finance
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2019-01-02+20,00020,000 total
    Exercise: $139.77Exp: 2029-01-01Common Stock (20,000 underlying)
Footnotes (1)
  • [F1]The stock option vests and becomes exercisable as to 1/48th of the total number of shares on February 2, 2019, then an additional 1/48th vests on each monthly anniversary thereafter, until such time as the option is 100% vested, subject to the reporting person's continued service through each vesting date.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4